Lupus Nephritis: Review of the Literature

被引：0
作者：
Adeel Zubair
Marianne Frieri
机构：
[1] Mayo Medical School,Department of Medicine and Pediatrics
[2] Nassau University,undefined
[3] Medical Center,undefined
来源：
Current Allergy and Asthma Reports | 2013年 / 13卷
关键词：
Systemic lupus erythematosus; Lupus nephritis; Vascular endothelial growth factor; TLR9; Diagnosis; Treatment; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Physicians in practice should be knowledgeable regarding several aspects of autoimmune disorders, especially systemic lupus erythematosus (SLE) and lupus nephritis. These disorders can present to the clinician’s clinic and private office regardless of their speciality. This review will discuss various aspects of SLE, its mechanisms of disease, role of accelerated atherosclerosis, proinflammatory cytokines, and therapeutic approaches. The role of vascular endothelial growth factor in which and plasma levels have been associated with disease activity, classification of severity, and diagnosis of lupus nephritis is addressed. Current treatment options, prognosis, and future therapeutic approaches and common side effects are also discussed.
引用
收藏
页码：580 / 586
页数：6
相关论文
共 179 条
  • [1] Smyth A(2010)A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis Clin J Am Soc Nephrol 5 2060-8
  • [2] Oliveira GH(2012)Lupus nephritis: an overview of recent findings Autoimmun Dis 2012 849684-60
  • [3] Lahr B(2002)Systemic lupus erythematosus in three ethic groups. XII. Risk factors for lupus nephritis after diagnosis Lupus 11 152-32
  • [4] de Zubiria Salgado A(2013)Mechanisms of disease for the clinician: systemic lupus erythematosus Ann Allergy Asthma Immunol 110 228-32
  • [5] Herrera-Diaz C(2012)Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches Curr Allergy Asthma Rep 12 25-4
  • [6] Bastian HM(2005)Rash, drug hypersensitivity and autoimmunity in a 20 year old Ann Allergy Asthma Immunol 95 111-4
  • [7] Roseman JM(2006)Toxic epidermal necrolysis in systemic lupus erythematosus Autoimmun Rev 5 160-9
  • [8] McGwin G(2003)Identification of masqueraders of autoimmune disease in the office Allergy Asthma Proc 24 421-63
  • [9] Frieri M(2009)European consensus statement on the terminology used in the management of lupus glomerulonephritis Lupus 18 257-24
  • [10] Frieri M(1999)Lupus nephritis J Am Soc Nephrol 10 413-50
12345678910